Trial Details

Not recruiting
Basic Information
Clinical ID c3353
Identifier NCT00392951
Trial Title Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions Autoimmune Pancytopenia;Autoimmune Lymphoproliferative Syndrome (ALPS);Evans Syndrome;Idiopathic Thrombocytopenic Purpura;Anemia, Hemolytic, Autoimmune;Autoimmune Neutropenia;Lupus Erythematosus, Systemic;Inflammatory Bowel Disease;Rheumatoid Arthritis
Interventions Drug: sirolimus
Participant Information
Sponsor Children's Hospital of Philadelphia
City -
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, CHILD, INFANT, TEENAGER
Study Design
Study Type Interventional
Phase PHASE1|PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date 2017-12-06
Completion Date -